World-Leading Genomics Expert Prof. Gudrun Moore Joins FetalFirst as Chief Scientific Advisor
FetalFirst pioneers quantum-accelerated computing solutions with GPU technology to transform fetal anomaly detection and decision support for clinicians and parents worldwide
London, UK – June 29, 2025 — FetalFirst, the next-generation fetal diagnostics and support platform, today announces the appointment of Professor Gudrun Moore as Chief Scientific Advisor, Genomics & Ethics. Prof. Moore, an internationally recognised leader in fetal genomics and co-creator of the internationally acclaimed Baby Bio Bank, brings over 30 years of expertise to FetalFirst’s mission: transforming how fetal anomalies are detected, understood, and managed—while supporting families at every step.
Prof. Moore serves as Emeritus Professor of Clinical and Molecular Genetics at UCL Institute of Child Health and was Deputy Director (Research2013-2015) at one of the world's largest pediatric research centers outside the United States. Her pioneering work on genomic imprinting has fundamentally transformed our understanding of fetal development, identifying critical genes such as IGF2, PHLDA2, GRB10, and DLK1—key regulators of fetal growth.
“Prof. Moore’s appointment is a pivotal milestone for FetalFirst,” “Her expertise, network and access to unparalleled research resources position us at the forefront of next-generation fetal diagnostics. We are committed to evidence-based technology that enhances, not replaces, clinical expertise.”
Through Prof. Moore’s leadership, FetalFirst gains access to the Baby Bio Bank, containing over 54,000 biological samples from more than 2,500 pregnancies. This resource focuses on complications affecting 20% of pregnancies, including fetal growth restriction, recurrent miscarriage, preterm birth, and pre-eclampsia.
Meeting the Challenges of Modern Pregnancy
With the average age of parents rising globally, the risk of pregnancy complications and congenital anomalies is increasing. At the same time, advances in high-resolution scanning technologies mean more anomalies are being detected than ever before. Yet, for many parents and clinicians, the flood of complex data and scarcity of fetal medicine specialists can lead to confusion, anxiety, and uncertainty about the best path forward.
FetalFirst addresses this urgent need by utilising the power of quantum-accelorated computing and advanced GPU technologies to deliver rapid, deep, and precise analysis of fetal scans and genetic data. The platform predicts not only the presence but also the likely severity of fetal anomalies, providing actionable insights for clinicians and empowering parents with clear, timely information.
Empowering Families and Clinicians—Beyond Technology
“Pregnancy is a race against time. Every day counts when a potential anomaly is detected. FetalFirst is designed to make conversations between specialists and parents more collaborative, less confusing, and focused on the best possible outcomes. Our technology helps clinicians and families make informed, timely decisions—whether that means accessing life-saving interventions, preparing for special care, or simply understanding all the options.”
Prof. Moore’s appointment brings world-class scientific leadership and access to the Baby Bio Bank, one of the world’s largest research database on pregnancy complications. This partnership ensures FetalFirst’s technology is grounded in the latest genomic discoveries and ethical best practices.
“FetalFirst is not just about advanced analysis; it’s about making the entire journey less isolating and more empowering. We connect families with world-class specialists for second opinions, offer trauma-informed mental health support, and provide a safe, moderated community forum for sharing experiences and advice”
Breaking Barriers, Bridging Global Healthcare Systems, Supporting Every Outcome
FetalFirst is committed to breaking down barriers to care—no matter where families live or what choices they face. In countries where options are limited, FetalFirst provides logistical support for accessing international interventions. For families of babies born with congenital anomalies, the platform connects parents to organizations and resources dedicated to specific disabilities, ensuring ongoing support and a better quality of life.
“By combining quantum-accelerated computing, AI, and compassionate human support, FetalFirst is setting a new global standard for fetal medicine. I am excited to contribute to FetalFirst’s mission of making understanding fetal medicine accessible worldwide. AI should complement clinical expertise, and FetalFirst’s approach aligns perfectly with this vision.”
“We’re here to give families clarity, confidence, and access to the right care, fast—helping save lives, improve outcomes, and support parents and babies, whatever their journey may be.”
